Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 +0.44%60 5-Year Yield-on-Cost % is 3.75 as of Sep. 13, 2026, which is 49% above its 10-year median of 2.51. GuruFocus rates TSE:7702 with a GF Score™ of 60/100 and a GF Value™ of 円509.07 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 313 Medical Devices & Instruments companies, JMS Co ranks better than 64.86% on this metric.
JMS Co's yield on cost for the quarter that ended in Mar. 2026 was 3.75.
The historical rank and industry rank for JMS Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:7702'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.54 Med: 2.51 Max: 4
Current: 3.75
During the past 13 years, JMS Co's highest Yield on Cost was 4.00. The lowest was 1.54. And the median was 2.51.
TSE:7702's 5-Year Yield-on-Cost % is ranked better than 64.86% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 2.52
vs TSE:7702: 3.75
JMS Co (TSE:7702) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
JMS Co 5-Year Yield-on-Cost % Related Terms
TSE:7702 vs ISRG, BDX, RMD: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, JMS Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where JMS Co's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of JMS Co is calculated as
JMS Co (TSE:7702) has a 5-Year Yield-on-Cost % of 3.75 as of Sep. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on JMS Co and its competitors. This is 49% above median its historical median of 2.51. Over the past decade, JMS Co's 5-Year Yield-on-Cost % has ranged from 1.54 to 4.00. According to the industry distribution chart, JMS Co ranks #110 out of 313 companies in the Medical Devices & Instruments industry, placing it in the top 35.1%.
Is JMS Co's 5-Year Yield-on-Cost % too high?
JMS Co's current 5-Year Yield-on-Cost % of 3.75 is 49% above median its 10-year median of 2.51. Over the past 10 years, this metric has ranged from a low of 1.54 to a high of 4.00. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.52. JMS Co's value of 3.75 is 48.8% above this industry median. Based on the distribution chart, JMS Co ranks #110 out of 313 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JMS Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #110 out of 313 companies for 5-Year Yield-on-Cost %. This puts JMS Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.52. JMS Co's value of 3.75 is 48.8% above this benchmark. Historically, JMS Co's own 5-Year Yield-on-Cost % has ranged from 1.54 to 4.00 over the past decade. While the company's 10-year median is 2.51 vs. the industry median of 2.52, JMS Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.52, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMS Co's current 5-Year Yield-on-Cost % of 3.75 is 48.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on JMS Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMS Co's current 5-Year Yield-on-Cost % is 3.75, which is 49% above median its own 10-year median of 2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Modestly Undervalued. The stock's GF Value™ is 円509.07, compared to a current price of 円453.00 — trading 11% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.75, which is 49% above median its 10-year median of 2.51 and 48.8% above the Medical Devices & Instruments industry median of 2.52. JMS Co's overall GF Score™ is 60/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For JMS Co (TSE:7702), the current 5-Year Yield-on-Cost % is 3.75 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円453.00 is trading 11% below its estimated GF Value™ of 円509.07.
GuruFocus considers JMS Co to be Modestly Undervalued.
Key valuation signals for TSE:7702:
5-Year Yield-on-Cost %: 3.75 (49% above median its 10-year median of 2.51)
GF Value™: 円509.07 vs. price of 円453.00 (11% below fair value)
Industry Position: 48.8% above the Medical Devices & Instruments median (#110 of 313)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
60GF Score
Get the complete analysis for TSE:7702
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
